List of Excipients in API topotecan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing topotecan
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | HYCAMTIN | topotecan | 0078-0672 | FERRIC OXIDE RED | |
Novartis Pharmaceuticals Corporation | HYCAMTIN | topotecan | 0078-0672 | GELATIN | |
Novartis Pharmaceuticals Corporation | HYCAMTIN | topotecan | 0078-0672 | GLYCERYL MONOSTEARATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing topotecan
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Accord Healthcare Inc | topotecan | 16729-243 | HYDROCHLORIC ACID |
Accord Healthcare Inc | topotecan | 16729-243 | SODIUM HYDROXIDE |
Accord Healthcare Inc | topotecan | 16729-243 | TARTARIC ACID |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for topotecan
Excipient focus: FERRIC OXIDE RED
topotecan drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Sandoz Inc | topotecan | 66758-101 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | topotecan | 0409-0302 |
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
Accord Healthcare Inc | topotecan | 16729-243 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
topotecan drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Sandoz Inc | topotecan | 66758-101 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | topotecan | 0409-0302 |
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
Accord Healthcare Inc | topotecan | 16729-243 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONOSTEARATE
topotecan drug variants containing GLYCERYL MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Sandoz Inc | topotecan | 66758-101 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing GLYCERYL MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | topotecan | 0409-0302 |
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
Accord Healthcare Inc | topotecan | 16729-243 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
topotecan drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | topotecan | 0409-0302 |
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
Accord Healthcare Inc | topotecan | 16729-243 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Sandoz Inc | topotecan | 66758-101 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED PALM OIL
topotecan drug variants containing HYDROGENATED PALM OIL
Company | Ingredient | NDC |
---|---|---|
Sandoz Inc | topotecan | 66758-101 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing HYDROGENATED PALM OIL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Hospira Inc | topotecan | 0409-0302 |
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
topotecan drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
Ingenus Pharmaceuticals LLC | topotecan | 50742-404 |
Novartis Pharmaceuticals Corporation | topotecan hydrochloride | 0078-0674 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Hospira Inc | topotecan | 0409-0302 |
Accord Healthcare Inc | topotecan | 16729-243 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
topotecan drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | topotecan | 0409-0302 |
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
Accord Healthcare Inc | topotecan | 16729-243 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Sandoz Inc | topotecan | 66758-101 |
>Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
topotecan drug variants containing TARTARIC ACID
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | topotecan | 0409-0302 |
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
Accord Healthcare Inc | topotecan | 16729-243 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing TARTARIC ACID
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Sandoz Inc | topotecan | 66758-101 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
topotecan drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Sandoz Inc | topotecan | 66758-101 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | topotecan | 0409-0302 |
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
Accord Healthcare Inc | topotecan | 16729-243 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
topotecan drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Hospira Inc | topotecan | 0409-0302 |
Teva Parenteral Medicines Inc | topotecan | 0703-4714 |
Accord Healthcare Inc | topotecan | 16729-243 |
>Company | >Ingredient | >NDC |
topotecan drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | topotecan | 0078-0672 |
Ingenus Pharmaceuticals LLC | topotecan | 50742-404 |
Sandoz Inc | topotecan | 66758-101 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.